<DOC>
	<DOCNO>NCT00672763</DOCNO>
	<brief_summary>The purpose study determine whether addition vitamin D standard corticosteroid improve onset remission active Crohn 's Disease , form Inflammatory Bowel Disease ( IBD ) .</brief_summary>
	<brief_title>Adjuvant Vitamin D With Corticosteroids Active Crohn 's Disease</brief_title>
	<detailed_description>Crohn 's Disease form Inflammatory Bowel Disease ( IBD ) . It cause abnormal immune-mediated gut inflammation chronic difficult treat . Symptoms often unpleasant ( e.g . abdominal pain , diarrhoea , disfigure fistulation ) often lead surgery remove diseased bowel . There emerge evidence Vitamin D , nutrient largely produce skin upon exposure sun-light , may possess property regulate immune system IBD . In addition , vitamin D deficiency appear common Inflammatory Bowel Disease . This study aim determine addition vitamin D standard corticosteroid treatment active Crohn 's Disease help achieve remission ( resolution symptom ) .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<criteria>1 . Active Crohn 's Disease Activity ( CDAI ) Score &gt; 200 450 ; 2 . Diagnosis IBD distribution disease previously confirm 3 . The participant able give inform consent form ; 4 . Stable dos follow concurrent IBD medication prior inclusion : 5aminosalicylates ( ≥4 week ) Thiopurines ( ≥8 week ) No corticosteroid ( within 4 week ) No biological agent ( within 8 week ) . 1 . Unable give inform write consent ; 2 . Co−existence chronic inflammatory condition 3 . Failure meet concurrent IBD medication criterion ; 4 . Hypercalcaemia ( Corrected serum calcium &gt; 2.66 mmol/L ) history vitamin D hypersensitivity ; 5 . Diagnosis flow : active tuberculosis , sarcoidosis , hyperparathyroidism , pseudohyperparathyroidism , nephrolithiasis , silicosis , liver failure , renal failure malignancy , active TB , sarcoidosis lymphoma granulomatous disease ; 6 . Known intolerance contraindication vitamin D trial medication ( i.e . corticosteroid / infliximab ) ; 7 . Biochemical disturbance enrolment : serum correct calcium &gt; 2.66 mmol/L ) serum creatinine &gt; 250 micromol/L ; 8 . Pregnancy breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Crohn 's Disease</keyword>
	<keyword>Inflammatory Bowel Disease</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Randomised</keyword>
	<keyword>Placebo</keyword>
</DOC>